Finance

Beta
Lists
PVLA:NASDAQ
Palvella Therapeutics Inc
$108.67
-5.36%
(-6.15) 1D
$108.67
0.00% (0.00)
After hours
Closed: Jun 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PVLA...
Open
$112.00
High
$114.48
Low
$105.62
Mkt. cap
1.56B
Avg. vol.
217.95K
Volume
374.16K
52-wk high
$151.18
52-wk low
$20.20
EPS
-$4.16
Beta
-0.14
Shares outstanding
14.34M
No. of employees
29
Open
$112.00
High
$114.48
Low
$105.62
Mkt. cap
1.56B
Avg. vol.
217.95K
Volume
374.16K
52-wk high
$151.18
52-wk low
$20.20
EPS
-$4.16
Beta
-0.14
Shares outstanding
14.34M
No. of employees
29
Analyst outlook
Analyst Ratings
Based on 11 analysts giving stock ratings to PVLA in the past 3 months
Strong Buy
Buy
11
Hold
0
Sell
0
12 month forecast
Based on 11 Wall Street analysts offering 12 month price targets for PVLA in the last 3 months.
Highest
Current $108.67
$270.00 (+148.46%)
Average
$234.89 (+116.15%)
Lowest
$210.00 (+93.25%)
News stories
From sources across the web
About Palvella Therapeutics Inc
CEO-
Employees29
Founded-
Headquarters-
SectorBiotechnology
Websitepalvellatx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
5.12M
6.53M
7.12M
9.33M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.13M
3.65M
4.18M
5.52M
Operating expense
9.25M
10.18M
11.30M
14.86M
Total operating expenses
9.25M
10.18M
11.30M
14.86M
Operating income
-9.25M
-10.18M
-11.30M
-14.86M
Other non operating income
443.00K
-286.00K
-191.00K
54.00K
EBT including unusual items
-9.47M
-11.34M
-12.71M
-15.77M
EBT excluding unusual items
-9.47M
-11.34M
-12.71M
-15.77M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-9.47M
-11.34M
-12.71M
-15.77M
Net profit margin
-
-
-
-
Earnings per share
-0.86
-1.03
-1.08
-1.20
Interest and investment income
690.00K
628.00K
520.00K
1.07M
Interest expense
-1.35M
-1.51M
-1.74M
-2.04M
Net interest expenses
-664.00K
-882.00K
-1.22M
-966.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer